Analysed SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) News Sources
Sagimet Raises $115M At Premium To Fund Phase 3 Acne Drug Trial – SGMT Stock Surges Pre-Market
30-09-2026
stocktwits.com
Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
01-10-2026
yahoo.com
Sagimet Biosciences Highlights 52-Week Acne Data, Sets U.S. Phase III Trial Launch
04-10-2026
marketbeat.com
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference
09-10-2026
yahoo.com
Sagimet Says Denifanstat Shows Continued Improvement in Acne Through 52 Weeks in China Trial
09-10-2026
yahoo.com
After Plunging 27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
15-10-2026
yahoo.com
Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne
22-10-2026
yahoo.com
Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne
23-10-2026
yahoo.com
What is the current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The current price of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is $9.56.
SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is $-0.02.
SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) since the previous trading day is -0.2088%.
What is the most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The most recent average sentiment score for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)?
The most recent sentiment for SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ) is .
SEC-8K** Filing Available For SAGIMET BIOSCIENCES INC-A (SGMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.